Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK14 | Q16539 | 12/20 | 0.41 |
| ▸ | MAPK11 | Q15759 | 7/20 | 0.41 |
| ▸ | ROCK2 | O75116 | 1/20 | 0.37 |
| ▸ | ROCK1 | Q13464 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 2/20 | 0.37 |
| ▸ | TP53 | P04637 | 1/20 | 0.37 |
| ▸ | RIPK2 | O43353 | 1/20 | 0.36 |
| ▸ | SUCNR1 | Q9BXA5 | 1/20 | 0.36 |
| ▸ | MAPK13 | O15264 | 1/20 | 0.36 |
| ▸ | MAPK12 | P53778 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3816739 | 0.97 | MAPK14 (0.42) | MAPK14MAPK11ROCK2ROCK1MAPT | |
| SCHEMBL3815544 | 0.92 | MAPK14 (0.43) | MAPK14MAPK11ROCK2ROCK1MAPT | |
| SCHEMBL3816240 | 0.91 | MAPK14 (0.51) | MAPK14MAPK11ROCK2ROCK1MAPT | |
| SCHEMBL3349897 | 0.90 | MAPK14 (0.45) | MAPK14MAPK11ROCK2ROCK1MAPT | |
| SCHEMBL3813707 | 0.90 | MAPK14 (0.45) | MAPK14MAPK11ROCK2ROCK1MAPT | |
| SCHEMBL3821471 | 0.90 | MAPK14 (0.47) | MAPK14MAPK11ROCK2ROCK1MAPT | |
| SCHEMBL3818327 | 0.88 | MAPK14 (0.45) | MAPK14MAPK11ROCK2ROCK1MAPT | |
| SCHEMBL3821065 | 0.88 | MAPK14 (0.45) | MAPK14MAPK11ROCK2ROCK1MAPT | |
| SCHEMBL3824492 | 0.88 | MAPK14 (0.46) | MAPK14MAPK11ROCK2ROCK1MAPT | |
| SCHEMBL3812258 | 0.88 | ROCK2 (0.44) | MAPK14MAPK11ROCK2ROCK1MAPK13 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1635824-B1 | 5-MEMBERED HETEROCYCLE-BASED P-38 INHIBITORS | NOVARTIS AG (CH) | 2009-08-19 | — | — | EP | claimed |